The Food and Drug Administration (FDA) has recently approved an innovative obesity medication from Eli Lilly that hold ...
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...
The FDA declared a shortage of popular weight-loss and diabetes drugs. Here's what that means for people who get generic ...
Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...
The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. | ...
The U.S. Food and Drug Administration declined to approve Lexicon Pharmaceuticals' add-on drug for type 1 diabetes and chronic kidney disease, the company said on Friday.